KR20080019902A - Manufacturing method of isoflavone, genistin and monascus sp., powder, gel, rice with genistein combined monacolin k - Google Patents

Manufacturing method of isoflavone, genistin and monascus sp., powder, gel, rice with genistein combined monacolin k Download PDF

Info

Publication number
KR20080019902A
KR20080019902A KR1020060082415A KR20060082415A KR20080019902A KR 20080019902 A KR20080019902 A KR 20080019902A KR 1020060082415 A KR1020060082415 A KR 1020060082415A KR 20060082415 A KR20060082415 A KR 20060082415A KR 20080019902 A KR20080019902 A KR 20080019902A
Authority
KR
South Korea
Prior art keywords
genistein
isoflavone
gcm
ethanol
powder
Prior art date
Application number
KR1020060082415A
Other languages
Korean (ko)
Other versions
KR100858280B1 (en
Inventor
김용훈
윤은경
Original Assignee
(주)엔앤비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)엔앤비 filed Critical (주)엔앤비
Priority to KR1020060082415A priority Critical patent/KR100858280B1/en
Publication of KR20080019902A publication Critical patent/KR20080019902A/en
Application granted granted Critical
Publication of KR100858280B1 publication Critical patent/KR100858280B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/05Mashed or comminuted pulses or legumes; Products made therefrom
    • A23L11/07Soya beans, e.g. oil-extracted soya bean flakes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/101Addition of antibiotics, vitamins, amino-acids, or minerals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/196Products in which the original granular shape is maintained, e.g. parboiled rice

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Preparation methods of isoflavone and genistein, a culture method of Monascus sp., with GCM(genistein combined monacolin K) using the genistein, and preparation methods of powder, gel and rice using the GCM are provided to separate high-purity genistein from isoflavone contained in bean or bean-curd refuse by using solubility, thereby obtaining high-priced genistein effectively. A preparation method of isoflavone comprises the steps of: (i) adding 1~3L of nucleic acid per 1kg of bean powder 2~4 times, stirring the mixture for 10hr, and filtering it to make fat-removed bean powder; (ii) adding 0.5~2L of a 80% ethanol aqueous solution per 700g of the fat-removed bean powder 2~5 times at room temperature, and stirring the mixture for 4~6hr to obtain isoflavone with a concentration of about 10%; and (iii) adding a 95% ethanol aqueous solution to 10g of the isoflavone, stirring the mixture at 70~90‹C for 30min to 1~3hr, filtering it, and vacuum-filtering the solvent to obtain isoflavone with a concentration of 50% or more. A preparation method of genistein comprises; adding 80~120ml of a 60~90% ethanol aqueous solution per 1g of isoflavone extracted from bean or bean-curd refuge, performing reflux-extraction at 70~90‹C for 10~30min, filtering the extract, quick-cooling it to 5~15‹C, and then obtaining genistein after 12~36hr. A culture method of Monascus sp., with GCM comprises: dissolving 0.1~1wt% of genistein in a 50~85% ethanol, adding 0.01~0.2wt% of the solution to a culture medium having a pH of 5~7, and culturing Monascus sp. A preparation method of gel using the GCM comprises: (a) dissolving 1.5~3g of lecithin in a solvent containing chloroform and methanol in a volume ratio of 2:1, based on 1g of Monascus sp. powder, and removing the solvent by an evaporator; (b) adding 50~60ml of water to the obtained substance, and stirring the mixture at high speed for 50~70min to make a homogenized suspension; (c) dissolving 1~5g of xanthan gum in 40~60ml of water to form the xanthan gum into gel; and (d) stirring the homogenized suspension and the gel-formed xanthan gum to make gel.

Description

이소플라본 제조방법과 제니스틴 제조방법 및 이를 이용한 모나콜린 케이를 함유하는 제니스테인을 갖는 홍국균 배양 방법과 이를 이용한 분말, 겔, 쌀 제조방법{Manufacturing method of Isoflavone, Genistin and Monascus sp., powder, gel, rice with Genistein Combined Monacolin K}Method for producing isoflavone and method for producing zenithine and culturing red yeast bacterium with genistein containing monacoline K using the same and manufacturing method for powder, gel and rice using the same {Manufacturing method of Isoflavone, Genistin and Monascus sp. with Genistein Combined Monacolin K}

도 1은 본 발명에 따른 GCM의 제조공정을 나타내는 도면1 is a view showing a manufacturing process of the GCM according to the present invention

도 2는 GCM함량에 의한 혈청 콜레스테롤 함량을 나타내는 그래프Figure 2 is a graph showing the serum cholesterol content by GCM content

도 3은 GCM함량에 의한 LDL-콜레스테롤 함량을 나타내는 그래프3 is a graph showing the LDL-cholesterol content by GCM content

도 4는 GCM함량에 의한 HDL-콜레스테롤 함량을 나타내는 그래프Figure 4 is a graph showing the HDL-cholesterol content by GCM content

본 발명은 이소플라본 제조방법과 제니스틴 제조방법 및 이를 이용한 홍국균 배양방법과 모나콜린 케이를 함유하는 제니스테인 제조방법에 관한 것으로, 보다 상세하게는 콩분말 혹은 비지로부터 이소플라본을 제조하고, 이를 이용하여 얻어진 제니스틴을 홍국(Monascus sp.) 발효 과정에 투입하여, 모나콜린 케이(Monacolin K)를 함유한 제니스테인(이하, GCM이라 함, Genistein Combined Monacolin K)을 갖는 홍국균 배양 방법에 관한 것이다.The present invention relates to a method for producing isoflavones and a method for producing zenithine, a method for culturing red yeast bacteria using the same, and a method for producing zenithine containing monacoline K. It relates to a method for culturing red yeast bacteria having genistein (hereinafter referred to as GCM, Genistein Combined Monacolin K) containing zenithine in Monascus sp. Fermentation process.

현대인의 식생활은 과도한 콜레스테롤의 생성 및 섭취에 따른 동맥경화증, 협심증 등의 혈관질환 질병과 여러 성인병이 문제가 되고 있으며, 화학합성을 통한 의약품 등의 부작용이 따라 안전한 천연소재를 이용한 콜레스테롤 생성억제 및 고지혈증 치료제의 개발이 절박한 실정이다.The diet of modern people is caused by vascular diseases such as arteriosclerosis and angina due to excessive cholesterol production and intake, and various adult diseases.In addition, cholesterol production suppression and hyperlipidemia using safe natural materials due to side effects such as drugs through chemical synthesis Development of therapeutics is urgent.

이에 대한 해결책으로 콩의 생리활성물질에 대한 관심이 높아지고 있는데, 콩에는 이소플라본, 단백질 분해효소 억제제, 엽산, 식이성 섬유, 사포닌, 식물성 스테롤 및 페놀성 물질 등이 존재하며, 이 중에서도 이소플라본은 에스트로겐과 유사한 구조로서 피토에스트로겐(Phytoestrogen)과 같은 생리적 기능이 있음이 밝혀져 있다. 이소플라본은 C 15 H10 O2의 분자식을 가진 화합물군으로 제니스테인(Genistein),다이드제인(Daidzein), 글리시테인, 글루코스 배당체 등 합계 12종류가 천연의 상태로 존재하고 있는 이성체로서 주로 배당체의 형태로 존재하는 물질인데, 이들 이성체 중에서 제니스테인과 다이드제인이 대부분이다. As a solution to this, there is a growing interest in soybean bioactive substances. Soybeans include isoflavones, protease inhibitors, folic acid, dietary fiber, saponins, vegetable sterols and phenolic substances. Estrogen-like structure has been found to have a physiological function such as phytoestrogen. Isoflavone is a compound having a molecular formula of C 15 H10 O2. Isoflavone is a glycoside that is present in a natural state of 12 kinds in total such as Genistein, Daidzein, Glycine and glucose glycosides. It is a substance which exists, and most of these isomers are Genistein and Dyzezein.

이중 이소플라본의 비배당체인 제니스틴은 독성이 거의 없으면서도, 단백질 효소 중 PTK(Protein Tyrosine Kinase)의 선택적 억제제, Topoisomerase II 억제제, 에스트로겐 역할 및 신생혈관작용억제제 등의 다양한 생리적 활성을 가지며, HMG-CoA 환원효소(reductase) 및 저밀도 지질 단백질(LDL) 수용체의 유전자를 적절히 조절하여 고지혈증에 유익한 효과를 가지는 것으로 밝혀지고 있어 의약분야에도 상당한 관심을 끌고 있다. Genistin, a non-glycoside of isoflavone, has little toxic effects and has various physiological activities such as selective inhibitor of PTK (Protein Tyrosine Kinase), Topoisomerase II inhibitor, estrogen role and angiogenesis inhibitor among protein enzymes, and HMG-CoA It has been found to have a beneficial effect on hyperlipidemia by appropriately regulating genes of reductase and low density lipid protein (LDL) receptors, which has attracted considerable attention in the medical field.

그런데, 제니스틴은 식품 중에서 유일하게 콩에만 존재하기 때문에, 콩 중에 함유된 성분을 추출하는 다양한 방법들이 개발되고 있는데, 이 중 한국공개특허 2001-0060419호에서는 콩 배아 및 콩 배아와 두부순물의 혼합액을 사용하여 열수 추출로서 피에이치를 조절한 뒤 데칸타를 통해 분리 추출된 액을 흡착공정 및 제반공정을 사용하여 분리하는 방법 등을 제시하고 있으나, 여전히 효율성 및 경제성 문제 등이 남아 있다. By the way, since only Geniestin is present in soybeans, various methods for extracting ingredients contained in soybeans have been developed. Among them, Korean Patent Laid-Open No. 2001-0060419 discloses a mixture of soybean embryos and soybean embryos and tofu sprouts. Although the method of controlling the pH as hot water extraction by using the method and separating the separated and extracted liquid through the decanter using the adsorption process and the general process, there are still problems such as efficiency and economical efficiency.

한편, 1979년 일본 동경대의 엔도 아끼라 교수는 콜레스테롤 수치를 저하시키는 천연물질 모나스커스 에스피피(Monascus SPP)를 개발하였는데, 일명 홍국 발효 산물인 모나콜린 케이(Monacolin K)는 체내에서 생산되는 콜레스테롤 생합성 경로의 속도 결정 단계인 HMG-CoA 환원효소를 특이적으로 억제함으로써 저밀도 지질 단백질(LDL)과 결합된 콜레스테롤 농도를 저하시켜 혈중 콜레스테롤 수치를 낮춰주며 몸에 이로운 고밀도 지질 단백질(HDL)-콜레스테롤 수치를 증가시키는 것으로 알려져 있다.Meanwhile, in 1979, Professor Endo Akira of Tokyo University in Japan developed Monascus SPP, a natural substance that lowers cholesterol levels. By specifically inhibiting HMG-CoA reductase, a rate-determining step, the cholesterol concentration associated with low-density lipoprotein (LDL) is lowered, lowering blood cholesterol levels and increasing high-density lipoprotein (HDL) -cholesterol levels It is known to make.

상기한 다양한 종래 기술들을 바탕으로 하여, 본 발명의 목적은 두부 생산공정에서 부산물로 발생하는 비지에서 고 함량의 이소플라본을 분리정제하여 고순도의 제니스틴을 용해도를 이용하여 분리함으로써, 원가절감에 따른 저비용으로 고가의 제니스틴을 효율적으로 획득하는 데 있다.Based on the various conventional techniques described above, an object of the present invention is to separate and purify a high content of isoflavones from the sewage produced as by-products in the tofu production process, and to separate high purity zenithine using solubility, resulting in low cost. As a result, it is possible to efficiently obtain expensive Zenithin.

본 발명의 또 다른 목적은, 상기 획득된 제니스틴을 홍국(Monascus sp.)발효 과정에 투입하여, 홍국균에 모나콜린 케이(Monacolin K)를 함유한 제니스테인(이하, GCM이라 함, Genistein Combined Monacolin K)을 함유하도록 하는 배양 방법을 제공하는 데 있다.Another object of the present invention, by injecting the obtained Genitine into the fermentation process of Monascus sp., Genistein (hereinafter referred to as GCM, Genistein Combined Monacolin K) containing Monacolin K It is to provide a culture method to contain.

상기한 목적을 달성하기 위한 본 발명의 특징은 콩분말 1kg에 대하여 1-3L의 핵산을 2-4회 반복해서 가하여 10시간 교반 한 후, 필터링하여 탈지된 콩 분말을 제조하는 탈지과정과, 탈지된 콩 분말 700g에 대하여 상온에서 0.5-2L의 80% 에탄올 수용액을 2-5회 반복하여 가하여 4-6시간 교반하여 10% 내외의 이소플라본을 얻는 10% 이소플라본 추출 과정과, 상기한 10% 내외의 이소플라본 10g에 95% 에탄올 수용액(aq. ethanol) 100-150mL를 첨가한 후 70-90℃에서 30분에서 1-3시간 교반한 후 여과한 다음 용매를 감압여과하여 제거함으로써 50% 이상의 이소플라본을 얻는 50% 이상의 이소플라본 추출과정으로 구성되는 이소플라본 제조방법과, 완전히 건조된 비지를 사용하여 상기한 탈지과정을 거치지 않고 10% 이소플라본 추출 과정과 50% 이상의 이소플라본 추출과정으로 구성되는 이소플라본 제조방법에 있다.A feature of the present invention for achieving the above object is a degreasing process for preparing skim soybean powder by filtering 1-3L of nucleic acid 2-4 times with respect to 1kg soybean powder and stirring for 10 hours, followed by filtering 10% isoflavone extraction process of adding 0.5-2L of 80% ethanol aqueous solution 2-5 times at room temperature and stirring for 4-6 hours to obtain isoflavones of about 10% After adding 100-150 mL of 95% aqueous solution of aq. Ethanol (aq. Ethanol) to 10 g of isoflavones inside and outside, the mixture was stirred for 1 hour at 70-90 ° C. for 30 minutes, filtered and the solvent was removed by filtration under reduced pressure. Isoflavone manufacturing method consisting of more than 50% isoflavone extraction process to obtain isoflavones, and 10% isoflavone extraction process and 50% or more isoflavone extraction process without degreasing process using completely dried paper felled Isoflavones.

그리고 추출된 이소플라본 1g에 대하여 60-90% 에탄올 수용액 80-120mL를 추가하여 70-90℃에서 10-30분간 환류 추출한 다음 필터링하고 5-15℃로 급속냉각한 후 12-36시간 경과시켜 제니스틴을 얻는 제니스틴 제조방법에 있다.Then, 80-120 mL of 60-90% ethanol aqueous solution was added to 1 g of extracted isoflavone, refluxed at 70-90 ° C for 10-30 minutes, filtered, rapidly cooled to 5-15 ° C, and then passed for 12-36 hours. It is in the manufacturing method of Genistin.

그리고 다른 특징은 제니스틴을 50-85% 에탄올에 0.1 내지 1% 용해하여 pH는 5-7로 조정된 배지에 0.01-0.2%첨가하여 홍국균을 배양하되, 상기한 제니스틴은 액상으로 첨가되는 홍국균이 모나콜린 케이를 함유하는 제니스테인 제조방법이다.And another feature is that 0.1 to 1% dissolved in 50-85% ethanol and added pH 0.01-0.2% to the medium adjusted to 5-7 cultivated red yeast bacteria, but the above-mentioned Zenithine is added to the liquid liquid It is a manufacturing method of genistein containing choline k.

또한, 본 발명은 생산된 홍국균체와 배양액을 균질화 한 후 60-90% 에탄올로 추출한 후 환류 냉각하고 필터로 여과하여 모나콜린 케이를 함유하는 제니스테인을 얻는 방법과, 상기한 모나콜린 케이를 함유하는 제니스테인 1g에 대하여 레시틴 1.5-3g을 클로로포름: 메탄올이 2:1로 혼합된 용매에 녹인 후 용매를 제거하고, 생성된 물질의 중량에 대하여 물 50-60mL를 넣은 후 50-70분간 고속 교반하여 균질화된 현탁액을 제조하고, 크산탄 검 1-5g을 물 40-60mL에 완전히 녹여 겔상으로 만든 후, 상기 균질화된 현탁액과 겔상의 크산탄 검을 교반하면서 섞어서 겔형으로 제조되는 것을 특징으로 하는 모나콜린 케이를 함유하는 제니스테인 제조방법에 특징이 있다.The present invention also homogenizes the produced hongguk cell and the culture solution, and then extracted with 60-90% ethanol, and reflux-cooled and filtered with a filter to obtain genistein containing Monacholine K, and containing the Monacholine K Dissolve 1.5-3 g of lecithin in a solvent mixed with 2: 1 methanol for 1 g of genistein, remove the solvent, add 50-60 mL of water to the weight of the resulting material, and homogenize by high-speed stirring for 50-70 minutes. To prepare a suspension, 1-5 g of xanthan gum was completely dissolved in 40-60 mL of water to make a gel, and then the homogenized suspension and gelled xanthan gum were mixed with stirring to prepare a monacoline kay. It is characteristic in the manufacturing method of genistein containing.

이하 본 발명의 실시예를 보다 상세하게 살펴본다.Hereinafter, an embodiment of the present invention will be described in more detail.

우선 본 발명에 따른 GCM의 제조 방법을 살펴보면, 콩과 비지로부터 50% 이상의 이소플라본을 추출한 후, 분리 정제 과정을 통하여 제니스틴을 얻고, 상기한 제니스틴을 홍국균과 함께 배양하여 모나콜린 케이가 함유된 제니스테인을 얻는다.First, look at the manufacturing method of the GCM according to the present invention, after extracting more than 50% isoflavones from soybeans and sesame, to obtain the genitine through the separation and purification process, and the above-mentioned zenithin cultured with the honggukyun genistein K containing Get

부가적으로, 상기한 GCM을 겔형으로 형성한다.In addition, the above-mentioned GCM is formed in a gel form.

1. One. 제니스틴Jennysteen (( GenistinGenistin ) 추출) extraction

(1) 이소플라본의 추출(1) Extraction of Isoflavones

3L의 둥근 플라스크에 콩 분말 1kg을 넣은 후 2L의 핵산(hexane)(2회 반복)을 가하여 10시간 교반 한 후, 필터링하여 탈지된 콩 분말 700g을 얻는 탈지 콩 분말을 제조하고, 700g의 탈지 콩 분말에 상온에서 1L의 80% 에탄올 수용액(aq, ethanol)(3회 반복)을 가하여 5시간 교반하여 10% 내외의 이소플라본 9g을 얻은 후, 여기에 95% 에탄올 수용액(aq. ethanol) 100mL를 첨가한 후 80℃에서 1시간 교 반한 후 글라스 필터(glass filter)로 여과한 다음 용매를 제거하여 50% 이상의 이소플라본 1.7g 을 얻는다.1 kg of soybean powder was added to a 3 L round flask, followed by stirring for 10 hours by adding 2 L of hexane (2 repetitions), followed by filtering to obtain skim soybean powder to obtain 700 g of soybean powder, and 700 g of soybean. To the powder was added 1 L of 80% aqueous ethanol solution (aq, ethanol) (repeat 3 times) at room temperature, and stirred for 5 hours to obtain 9 g of isoflavones of about 10%. Then, 100 mL of 95% aqueous ethanol solution (aq. Ethanol) was added. After the addition, the mixture was stirred at 80 ° C. for 1 hour, filtered through a glass filter, and then the solvent was removed to obtain 1.7 g of isoflavone of 50% or more.

그리고 상기한 콩 분말을 이용한 이소플라본 추출 외에 비지를 사용할 경우에는 두부공정에서 나온 비지를 건조 오븐(dry oven)에서 100-150℃에서 수분함량 10%이하가 되도록 완전히 건조한 후, 700g의 건조 비지에 상온에서 1L의 80% 에탄올 수용액(aq, ethanol)(3회 반복)을 가하여 5시간 교반하여 10% 내외의 이소플라본 9g을 얻은 후, 여기에 95% 에탄올 수용액(aq. ethanol) 100mL를 첨가한 후 80℃에서 1시간 교반한 후 글라스 필터(glass filter)로 여과한 다음 용매를 제거하여 50% 이상의 이소플라본 1.7g 을 얻는다.In addition to using isoflavone extract using soybean powder, the bean curd from the tofu process is completely dried in a dry oven at 100-150 ° C. to have a moisture content of 10% or less, and then dried in 700 g of dry bean curd. After adding 1 L of 80% ethanol (aq, ethanol) (3 times) at room temperature and stirring for 5 hours to obtain 10 g of isoflavones of about 10%, 100 mL of 95% ethanol solution (aq. Ethanol) was added thereto. After stirring at 80 ° C. for 1 hour, the product was filtered with a glass filter, and then the solvent was removed to obtain 1.7 g of isoflavone at least 50%.

상기한 이소플라본 추출과정에서 비지에 비하여 탈지 콩 분말이 이소플라본 추출 수율이 우수함을 알 수 있다.In the isoflavone extraction process, it can be seen that the skimmed soybean powder has a superior yield of isoflavone extraction compared to the busy paper.

(2) 고농도 이소플라본으로부터 제니스틴의 분리 및 재결정화(2) Isolation and Recrystallization of Genistin from Highly Concentrated Isoflavones

상기한 이소플라본 제조과정에서 얻어진 50% 글리코사이드 이소플라본 2g을 60, 70, 80 및 90% 에탄올 수용액(aquous ethanol) 200mL에 넣어서 60, 70, 80 및 90℃에서 20분간 환류(reflux)한 다음, 세라믹 필터를 이용하여 재빨리 거른 후, 급속으로 10℃ 부근으로 냉각시키면, 순수한 엷은 노란색의 제니스테인이 생성되기 시작한다. 다음날 필터링하여 제니스틴을 얻고, 이를 다시 80% 에탄올 수용액에 재결정하여 순수한 제니스틴을 얻는다.2 g of 50% glycoside isoflavone obtained in the above-described isoflavone preparation process was added to 200 mL of 60, 70, 80 and 90% aqueous solution of aquous ethanol and refluxed at 60, 70, 80 and 90 ° C. for 20 minutes. After filtering quickly using a ceramic filter and rapidly cooling to around 10 ° C., pure pale yellow genistein starts to form. The following day is filtered to obtain genistin, which is then recrystallized in 80% aqueous ethanol solution to obtain pure genistin.

제니스틴 추출 과정에서 에탄올 수용액의 농도에 따른 제니스틴의 수율의 변화는 표 1과 같이 80-90% 농도에서 비슷한 경향을 보이며, 최대의 조건은 80% 함량에서 최대의 수율을 거두었다.In the process of extracting Genistin, the change of yield of Genistin according to the concentration of aqueous ethanol showed similar tendency at 80-90% concentration as shown in Table 1, and the maximum condition was the maximum yield at 80% content.

aquous ethanol 함량          aquous ethanol content Genistin 수율Genistin yield 90%90% 0.640.64 80%80% 0.680.68 70%70% 0.560.56 60%60% 0.460.46

표 1은 80℃에서 에탄올 수용액 농도에 따른 제니스틴의 수율 변화를 나타낸다.Table 1 shows the change in yield of geninistin with the concentration of aqueous ethanol at 80 ℃.

그리고 80% 에탄올 수용액에서 추출 온도 변화에 따른 수율 변화는 표 2와 같이 80-90℃에서 최대 수율을 보였으며, 온도가 80℃ 이하로 내려감에 따라 수율의 감소를 나타내었다.The yield change according to the extraction temperature change in 80% ethanol aqueous solution showed the maximum yield at 80-90 ℃ as shown in Table 2, the yield was reduced as the temperature is lowered below 80 ℃.

추출온도          Extraction temperature Genistin 수율Genistin yield 90℃90 ℃ 0.680.68 80℃80 ℃ 0.680.68 70℃70 ℃ 0.60.6 60℃60 ℃ 0.50.5

표 2는 80% 에탄올 수용액에서 추출 온도에 따른 제니스틴의 수율 변화를 나타낸다.Table 2 shows the change in yield of genistin with extraction temperature in 80% ethanol aqueous solution.

2. 2. GCMGCM 배양 culture

(1) 재료 및 균주(1) materials and strains

실험용 재료는 이소플라본에서 분리, 재결정화 한 제니스틴을 사용하였으며, 균주는 한국종균협회에서 분양받은 홍국균인 Monascus pilosus KCCM 60084를 사용하였다.Experimental materials were Genistin, which was isolated and recrystallized from isoflavones. Strain was used as Monascus pilosus KCCM 60084, which is a red yeast bacterium.

(2) (2) 홍국균Red yeast 배양 배지 선택 Culture medium selection

배지badge

홍국균의 생성에 유효한 배지의 종류를 검토하여 본 균주에 가장 적합한 배지를 선발하였다. 배지의 조건은 아래 표 3과 같으며 pH는 모두 6.0으로 조정하였다.The media most suitable for the production of erythrocytes were examined to select the most suitable media for this strain. The conditions of the medium are shown in Table 3 below, and the pHs were all adjusted to 6.0.

Figure 112006062440174-PAT00001
Figure 112006062440174-PAT00001

표 3은 배지의 종류와 조성을 나타낸다.Table 3 shows the types and compositions of media.

종배양Cultivation  And 본배양Main culture

종 배양용 배지는 Mizutani 배지에 초순수(d-water) 100mL를 첨가하여 사용하였으며, 보존 중인 균주는 동일 배지를 사용하여 30℃ 인큐베이터에서 150rpm으로 7일간 계대 배양하여 활성화한 후 동일 배지 7mL씩을 넣은 캡시험관을 사용하여 같은 조건으로 7일간 배양하였다.Species culture medium was used by adding 100 mL of ultrapure water (d-water) to Mizutani medium, and the preserved strains were activated by subcultured at 150 rpm in a 30 ° C incubator for 7 days using the same medium, and then capped with 7 mL of the same medium. Incubated for 7 days under the same conditions using a test tube.

본 배양은 250mL의 삼각플라스크에 배지 100mL를 넣어 121℃에서 15분간 멸균한 후 종 배양액을 넣어 30℃의 인큐베이터에서 10일간 배양하였다.In this culture, 100 mL of medium was added to a 250 mL Erlenmeyer flask and sterilized at 121 ° C. for 15 minutes, followed by a seed culture solution and incubated in an incubator at 30 ° C. for 10 days.

균의 증식도 및 색소함량Growth rate and pigment content of bacteria

균의 증식도는 배지에 번식한 균체를 핀셋으로 꺼내어 습기를 제거한 후 생체중량을 측정하였으며, 배지 100mL 당 성장한 균체 g수로 나타내었다. 색소함량은 배양액과 균체를 균질기로 12,000rpm에서 5분간 파쇄한 후 10mL를 취하고 95% 에탄올 50mL를 가하여 15분 동안 색소를 출출하였으며, 여과 후 흡광도를 500nm에서 측정하였다.The growth rate of the bacteria was determined by removing the moisture from the cells grown in the medium with tweezers, and then measuring the biomass. The number of cells grown per 100 mL of the medium was expressed. The pigment content was pulverized culture medium and cells with a homogenizer for 5 minutes at 12,000rpm, 10mL was taken and 50mL of 95% ethanol was added for 15 minutes, the absorbance was measured at 500nm after filtration.

상기한 홍국균주의 증식도 조사 결과, 홍국균의 경우 30℃에서 10일간 배양한 균체의 무게는 MM에서 26.9g/100mL로 가장 높았으며, LM, GY 는 각각 15.5-17.2g/100mL를 나타내었다. 또 YM, TM은 8.2-10.3g/100mL으로 상대적으로 낮은 균체 생성량을 보였다. 이에 본 배양실험에서는 MM배지를 이용하여 실험을 수행하였다.As a result of the proliferation of the hongguk strain, the weight of honggukyun cultured at 30 ° C for 10 days was the highest as 26.9g / 100mL in MM, and LM and GY showed 15.5-17.2g / 100mL, respectively. In addition, YM, TM showed a relatively low cell production amount of 8.2-10.3g / 100mL. In this culture experiment was carried out using the MM medium.

(3) 최적의 제니스틴 형태 선택(3) Choosing the Best Geninisine Form

GCM 최적화에 미치는 제니스틴의 형태를 알아보기 위하여 분말과 70% 에탄올에 0.5% 용해한 용액을, 0-1.0%의 구간으로 배지에 첨가하고, 홍국균 1-5g을 100ml배지에 첨가하여 30℃ 인큐베이터에 7-14일(본 발명의 실시예에서는 10일)간 배양하였다. 그 결과 표 4에 나타내는 바와 같이 분말로 첨가한 것은 쉽게 용해되기 어려워 배양 후 아랫부분에 일정량 제니스틴이 그대로 남아있는 반면, 70% 에탄올에 용해하여 첨가한 경우 배지에 그대로 용해되어 홍국 배양에 바로 이용되어 높은 색소와 향을 생성하였다. 이에 제니스틴의 형태는 액상이 우수한 것으로 나타났다.To determine the morphology of Zenithine on GCM optimization, 0.5% dissolved in powder and 70% ethanol was added to the medium in the range of 0-1.0%, and 1-5 g of red yeast bacteria were added to 100 ml medium and placed in a 30 ° C incubator. Incubated for -14 days (10 days in the example of the present invention). As a result, as shown in Table 4, it was difficult to easily dissolve the powder, so that after the incubation, a certain amount of zenistine remained in the lower part, but when dissolved and added to 70% ethanol, it was dissolved in the medium and used directly in the culture of red yeast rice. It produced high pigments and aromas. As a result, the shape of the genistin was excellent in the liquid phase.

FungiFungi 첨가형태Addition form 결과result 용해정도Solubility 균체 생성Cell generation 색소생성Pigmentation incense Monascus pilosus 60084Monascus pilosus 60084 controlcontrol -- ++ ++ ++ Monascus pilosus 60084Monascus pilosus 60084 분말powder -- ++++ ++ ++++ Monascus pilosus 60084Monascus pilosus 60084 액상Liquid ++ ++++ ++++ ++++

표 4는 제니스틴의 첨가형태에 따른 홍국 배양 결과를 나타낸다.Table 4 shows the results of cultured red yeast rice according to the addition form of Genistin.

(4) 제니스틴 첨가 조건 선택(4) Selecting Geninisine Conditions

0.1% 제니스틴의 70% 에탄올 첨가조건을 검토하기 위하여 0-1.0%의 구간으로 첨가하였다. 에탄올의 순도가 높아질수록 제니스틴의 용해도 쉬웠으나, 70% 에탄올로 용해한 경우까지 균체와 색소가 생성된 반면 95% 첨가구간에서는 배양이 일어나지 않았다. 이에 용해된 에탄올의 첨가량 최적조건을 균의 증식도와 색소함량으로 측정하였다.In order to examine the conditions for adding 70% ethanol of 0.1% geninisine, 0% was added in a range of 1.0%. The higher the purity of ethanol, the easier the solubility of genistin was, but the cells and pigments were produced until dissolution with 70% ethanol, while no culture occurred in the 95% addition section. The optimum condition of the amount of ethanol dissolved therein was measured by the growth rate of the bacteria and the pigment content.

70% ethanol 용해 genistin 첨가량(mL) 70% ethanol dissolved genistin addition amount (mL) 균체 증식량(g/100mL)Cell growth rate (g / 100mL) 색소함량Pigment Content 00 55 ++ 0.050.05 1010 ++ 0.10.1 1212 ++++ 0.50.5 2020 ++++++ 1One -- --

표 5는 제니스테인 첨가량에 따른 증식도와 색소함량을 나타낸다.Table 5 shows proliferation and pigment content according to the amount of genistein added.

그 결과, 제니스틴은 70% 에탄올에 용해하여 0.5mL를 첨가한 구간에서 가장 우수한 배양이 이루어짐을 알 수 있었다.As a result, it was found that Zenithine was the best culture in the section in which 0.5 mL was dissolved in 70% ethanol.

3. 3. GCMGCM 제조 방법 Manufacturing method

홍국균체와 배양액을 균질화 한 후 60-90% 에탄올로 추출한 후 환류 냉각하고 필터로 여과하여 GCM을 얻는다.After homogenizing hongguk cell and culture, extract with 60-90% ethanol, reflux and filter to obtain GCM.

4. 4. GCMGCM 효능에 대한 실험 Experiment on efficacy

(1) 식이 첨가에 대한 영향(1) Effect on dietary addition

GCM이 랫드의 고지혈증에 미치는 영향을 조사하기 위해 암수 랫드에 1% 콜레스테롤과 GCM 0.3%, 0.6% 그리고 3%를 특수 사료와 함께 섭취시켰다. 약 1개월 동안 자유식이 후 혈액을 채취하여 혈청의 총콜레스테롤, HDL, LDL 그리고 중성지방 (TG)을 측정하였으며 체중증감과 식이 효율 (Food efficiency ratio: FER)에 따른 GCM의 효과를 확인하였다.To investigate the effects of GCM on hyperlipidemia in rats, male and female rats were fed 1% cholesterol and 0.3%, 0.6% and 3% GCM with special diets. Blood was collected after free diet for about 1 month to measure serum total cholesterol, HDL, LDL and triglyceride (TG), and the effect of GCM on weight gain and food efficiency ratio (FER) was confirmed.

실험동물 및 식이Laboratory Animals and Diet

SD(Sprague-Dawley)계통의 특정병원균 부재(SPF) 랫드는 (주)오리엔트에서 암수 각 7주령을 구입하여 사용하였다. 7주령의 SD를 1주일간 적응시킨 후 각 군당 5마리씩으로 나누고, 식이는 AIN-76 diet를 이용하였다. 시험물질은 1% cholesterol과 0.3%, 0.6% 그리고 3% GCM을 사료와 혼합하여 투여하였다. 시험군의 구성은 1% cholesterol 투여군 (HC), 1% cholesterol + 0.3% GCM 투여군 (0.3% GCM), 1% cholesterol + 0.6% GCM 투여군 (0.6% GCM), 1% cholesterol + 3% GCM (3% GCM)으로 나누었다. SPF rats of SD (Sprague-Dawley) strains were purchased from Orient Co., Ltd. for 7 weeks of age. Seven-week-old SD was acclimated for one week and divided into five animals in each group. The diet was AIN-76 diet. Test substance was administered by mixing 1% cholesterol, 0.3%, 0.6% and 3% GCM with feed. The test group consisted of 1% cholesterol (HC), 1% cholesterol + 0.3% GCM (0.3% GCM), 1% cholesterol + 0.6% GCM (0.6% GCM), 1% cholesterol + 3% GCM (3 % GCM).

혈청 지질분석Serum Lipid Analysis

채혈 전 1시간 절식시킨 후 ether로 마취시켜 복부대동맥에서 채혈하였으며, 실온에서 30분간 방치 후 4℃, 3,000rpm에서 20분간 원심분리 하였다. 혈청의 total cholesterol, HDL-cholesterol 및 triglyceride 는 효소법에 의한 kit(아산제약, 한국)를 사용하여 흡광도를 측정[Perkinelmer, VICTO3 family) 하였으며, LDL-cholesterol은 Friedewald식Total cholesterol-(HDL-cholesterol+TG/5)]에 의해 계산하였다.Fasting for 1 hour before blood collection, anesthesia was performed with ether, and blood was collected from the abdominal aorta. Centrifugation was performed at 4 ° C. and 3,000 rpm for 20 minutes. Total cholesterol, HDL-cholesterol, and triglyceride in serum were measured by absorbance (Perkinelmer, VICTO3 family) using an enzyme-based kit (Asan Pharmaceutical, Korea). / 5)].

식이 효율측정Dietary Efficiency

식이 섭취량은 1주일에 2번씩 측정하였으며, 체중은 1주당 1번씩 측정하였다. 식이효율(food efficiency ratio: FER)은 3주간의 사육기간 동안의 체중증가량을 같은 기간 동안 섭취한 식이 섭취량으로 나누어 산출하였다.Dietary intake was measured twice a week and body weight was measured once per week. The food efficiency ratio (FER) was calculated by dividing the weight gain during the three week breeding period by the dietary intake during the same period.

통계학적 방법Statistical method

SAS를 이용하여 ANOVA를 통해 유의성을 검증한 후 Duncan‘s multiple range test를 실행하였다.After verifying significance through ANOVA using SAS, Duncan's multiple range test was performed.

상기한 실험결과는 아래와 같다.The experimental results are as follows.

사망률과 임상적 관찰Mortality and Clinical Observation

시험기간 동안 GCM 섭취에 의한 동물의 사망이나 육안적으로 특이한 임상적 증상은 없었다.There were no deaths or grossly clinical signs of animals from GCM intake during the study.

혈청 콜레스테롤Serum cholesterol

총 콜레스테롤 (Total cholesterol: TC)의 함량은 표 6에 나타내는 바와 같이 3% GCM군이 유의적으로 가장 낮았고, LDL-콜레스테롤의 함량 역시 3% GCM군이 가장 낮았다.As shown in Table 6, the total cholesterol (TC) content was significantly lower in the 3% GCM group, and the content of LDL-cholesterol was also the lowest in the 3% GCM group.

그리고 중성지방 (Triglyceride / TG)의 함량은 HC군이 가장 높고 나머지 각 군간 유의적인 차이는 없었으며, HDL-콜레스테롤의 함량은 HC군에 비하여 첨가량이 증가할수록 유의적으로 높아짐을 알 수 있다.The content of triglyceride / TG was the highest in HC group, and there was no significant difference among the other groups, and the content of HDL-cholesterol increased significantly as the amount of addition increased compared to HC group.

TCTC LDLLDL TGTG HDLHDL meanmean SDSD meanmean SDSD meanmean SDSD meanmean SDSD HCHC 233.76a1 )2) 233.76 a1 ) 2) 28.28 28.28 193.50a 193.50 a 10.35 10.35 63.68NS3 ) 63.68 NS3 ) 9.98 9.98 19.88b 19.88 b 2.15 2.15 0.3% GCM0.3% GCM 182.03b 182.03 b 28.03 28.03 149.85b 149.85 b 12.08 12.08 50.79 50.79 9.10 9.10 26.50a 26.50 a 3.70 3.70 0.6% GCM0.6% GCM 148.27c 148.27 c 11.73 11.73 117.86c 117.86 c 16.36 16.36 49.82 49.82 4.14 4.14 31.18a 31.18 a 5.09 5.09 3% GCM3% GCM 134.20c 134.20 c 7.81 7.81 101.88c 101.88 c 12.08 12.08 49.73 49.73 10.98 10.98 30.34a 30.34 a 3.21 3.21

상기 표 6에서 단위는 mg/dl이고, NS는 no significance를 의미한다.In Table 6, the unit is mg / dl, and NS means no significance.

체중변화Weight change

체중의 증가량 변화는 표 7에 나타내는 바와 같이 군간의 유의적인 차이는 없었다.As shown in Table 7, there was no significant difference between the groups.

Figure 112006062440174-PAT00002
Figure 112006062440174-PAT00002

표 7에서 단위는 g이다.In Table 7, the unit is g.

식이 효율 (Food efficiency ratio: Food efficiency ratio: FERFER ))

표 8에서 나타내는 바와 같이 HC군과 3% GCM 투여군은 유의적인 차이가 없었으나 0.3% GCM군, 0.6% GCM군은 HC군보다 유의적으로 감소하였다.As shown in Table 8, there was no significant difference between the HC group and the 3% GCM-administered group, but the 0.3% GCM group and 0.6% GCM group were significantly reduced than the HC group.

GroupGroup FER1 ) FER 1 ) HCHC 0.247±0.0160.247 ± 0.016 0.3% GCM0.3% GCM 0.197±0.0190.197 ± 0.019 0.6% GCM0.6% GCM 0.225±0.0150.225 ± 0.015 3% GCM3% GCM 0.247±0.0220.247 ± 0.022

표 8에서 FER은 weight gain/diet intake이다.In Table 8, FER is weight gain / diet intake.

(2) 경구투여에 대한 영향(2) effect on oral administration

실험동물 및 식이Laboratory Animals and Diet

SD (Sprague-Dawley) 계통의 특정병원균 부재 (SPF) 랫드는 (주)오리엔트에서 암수 각 7주령을 구입하여 사용하였다. 7주령의 SD를 1주일간 적응시킨 후 각 군당 5마리씩으로 나누고, 식이는 AIN-76 diet를 이용하였다. 시험물질은 1% cholesterol을 사료와 혼합하여 투여하였다. 시험군의 구성은 음성대조군 (NC), 1% cholesterol 투여군 (HC), 1% cholesterol+0.165g GCM/kg (HC1×GCM), 1% cholesterol+0.330g GCM/kg (HC2×GCM), 1% cholesterol+0.825 GCM/kg (HC5×GCM) 투여군으로 구성된다.SPF rats of SD (Sprague-Dawley) strain were purchased from Orient Co., Ltd. for 7 weeks of age. Seven-week-old SD was acclimated for one week and divided into five animals in each group. The diet was AIN-76 diet. Test substance was administered by mixing 1% cholesterol with feed. The test group consisted of negative control group (NC), 1% cholesterol-administered group (HC), 1% cholesterol + 0.165g GCM / kg (HC1 × GCM), 1% cholesterol + 0.330g GCM / kg (HC2 × GCM), 1 % cholesterol + 0.825 GCM / kg (HC5 × GCM) administration group.

혈청 지질분석Serum Lipid Analysis

채혈 전 1시간 절식시킨 후 ether로 마취시켜 복부대동맥에서 채혈하였으며, 실온에서 30분간 방치 후 4℃, 3,000rpm에서 20분간 원심분리 하였다. 혈청의 total cholesterol, HDL-cholesterol 및 triglyceride 는 효소법에 의한 kit (아산제약, 한국)를 사용하여 흡광도를 측정 [Perkinelmer, VICTO3 family) 하였으며, LDL-cholesterol은 Friedewald식 Total cholesterol-(HDL-cholesterol+TG/5)]에 의해 계산하였다.Fasting for 1 hour before blood collection, anesthesia was performed with ether, and blood was collected from the abdominal aorta. Centrifugation was performed at 4 ° C. and 3,000 rpm for 20 minutes. Total cholesterol, HDL-cholesterol and triglyceride in serum were measured by absorbance using the enzyme-based kit (Asan Pharmaceutical, Korea) [Perkinelmer, VICTO3 family). / 5)].

식이 효율측정Dietary Efficiency

식이 섭취량과 체중 시험기간 동안 매일 측정하였으며 식이 효율 (food efficiency ratio: FER)은 시험기간 동안의 체중증가량을 같은 기간 동안 섭취한 식이 섭취량으로 나누어 산출하였다.Dietary intake and body weight were measured daily during the test period. The food efficiency ratio (FER) was calculated by dividing the weight gain during the test period by the amount of food intake consumed during the same period.

통계학적 방법Statistical method

SPSS 12.0K를 이용하여 일원 배치분산분석 (ANOVA test)를 통하여 연구의 모든 자료를 분석하였다.All data in this study were analyzed by ANOVA test using SPSS 12.0K.

이상의 실험 결과를 하기에서 살펴본다.The experimental results will be described below.

사망률과 임상적 관찰Mortality and Clinical Observation

시험기간 동안 GCM 섭취에 의한 동물의 사망이나 육안적으로 특이한 임상적 증상은 없었다.There were no deaths or grossly clinical signs of animals from GCM intake during the study.

혈청 콜레스테롤 (total cholesterol : Serum cholesterol: TCTC ))

도 1에 나타내는 바와 같이 총 콜레스테롤 함량은 음성대조군 (NC)과 1% 콜레스테롤 처리한 HC군은 각각 72.83±7.59mg/dl, 231.33±53.17mg/dl으로 콜레스테롤 식이에 의해 약 3배 정도 증가하였다. HC1×GCM, HC2×GCM, HC5×GCM의 시험군인 경우 각각 181.41±14.68mg/dl, 135.33±11.07mg/dl, 114.40±6.51mg/dl으로 HC1×GCM을 제외한 나머지 두 고농도 투여군은 HC군과 유의한 차이가 있다. 특히 시험물질의 농도가 높을수록 혈청 콜레스테롤 함량이 유의하게 감소하는 경향을 보이고 있다.As shown in FIG. 1, the total cholesterol content of the negative control group (NC) and the HC group treated with 1% cholesterol was 72.83 ± 7.59mg / dl and 231.33 ± 53.17mg / dl, respectively, about 3 times higher by the cholesterol diet. In the test groups of HC1 × GCM, HC2 × GCM, and HC5 × GCM, 181.41 ± 14.68mg / dl, 135.33 ± 11.07mg / dl and 114.40 ± 6.51mg / dl, respectively. There is a significant difference. In particular, the higher the concentration of the test substance tends to significantly decrease the serum cholesterol content.

중성지방 (Triglyceride ( TriglycerideTriglyceride : TG) : TG)

중성지방 함량은 음성대조군 (NC)과 1% 콜레스테롤 처리한 HC군은 각각 72.43±24.67 mg/dl, 45.95±9.65mg/dl로 콜레스테롤 식이에 의해 다소 감소되는 경향은 있으나 두 군간의 유의한 차이는 없다. HC1×GCM, HC2×GCM, HC5×GCM의 시험군인 경우 각각 54.59±22.01mg/dl, 28.41±9.70mg/dl, 26.20±5.45mg/dl로 HC1×GCM을 제외한 나머지 두 고농도 투여군은 HC군과 유의하게 중성지방 함량이 감소하였다. The triglyceride content of the negative control group (NC) and HC group treated with 1% cholesterol was 72.43 ± 24.67 mg / dl and 45.95 ± 9.65mg / dl, respectively, which tended to be slightly decreased by cholesterol diet, but there was a significant difference between the two groups. none. In the test groups of HC1 × GCM, HC2 × GCM, and HC5 × GCM, 54.59 ± 22.01mg / dl, 28.41 ± 9.70mg / dl, and 26.20 ± 5.45mg / dl, respectively. There was a significant decrease in triglyceride content.

LDL-cholesterol 함량LDL-cholesterol content

LDL-cholesterol 함량은 도 2에 나타내는 바와 같이 음성대조군 (NC)과 1% 콜레스테롤 처리한 HC군은 각각 20.59±6.25mg/dl 으로 콜레스테롤 식이에 의해 약 5배 정도 증가하였다. HC1×GCM, HC2×GCM, HC5×GCM의 시험군인 경우 각각 144.82±14.03mg/dl, 99.76±8.46mg/dl, 77.49±13.64mg/dl로 HC1×GCM을 제외한 나머지 두 고농도 투여군은 HC군과 유의한 차이가 있다.As shown in Fig. 2, the LDL-cholesterol content of the negative control group (NC) and the HC group treated with 1% cholesterol was 20.59 ± 6.25mg / dl, respectively, about 5 times increased by the cholesterol diet. In the test group of HC1 × GCM, HC2 × GCM, and HC5 × GCM, 144.82 ± 14.03mg / dl, 99.76 ± 8.46mg / dl, 77.49 ± 13.64mg / dl, respectively. There is a significant difference.

HDL-cholesterol 함량HDL-cholesterol content

HDL-cholesterol 함량은 도 3에 나타내는 바와 같이 음성대조군 (NC)과 1% 콜레스테롤 처리한 HC군은 각각 37.75±4.32mg/이, 27.06±8.61 mg/dl으로 콜레스테롤 식이에 의해 다소 감소되는 경향은 있으나 두 군간 유의한 차이는 없다. HC1×GCM, HC2×GCM, HC5×GCM 의 시험군인 경우 각각 25.67±7.34mg/dl, 31.68±8.24mg/dl으로 HC군과 유의한 차이가 없다.As shown in FIG. 3, the HDL-cholesterol content of the negative control group (NC) and the HC group treated with 1% cholesterol was 37.75 ± 4.32mg /, and 27.06 ± 8.61 mg / dl, respectively. There is no significant difference between the two groups. In the test group of HC1 × GCM, HC2 × GCM and HC5 × GCM, there was no significant difference from HC group as 25.67 ± 7.34mg / dl and 31.68 ± 8.24mg / dl, respectively.

체중변화Weight change

실험기간 동안 체중증가는 표 9에 나타내는 바와 같이 유의한 차이가 없다 (P>0.05).Body weight gain was not significantly different during the experimental period as shown in Table 9 (P> 0.05).

Figure 112006062440174-PAT00003
Figure 112006062440174-PAT00003

표 9에서 단위는 g이다.In Table 9 the unit is g.

식이 효율 (Food efficiency ratio: FER ) Food efficiency ratio ( FER )

식이 효율 역시 표 10에 나타내는 바와 같이 유의적인 차이가 없다.(P>0.05).Dietary efficiency was also not significantly different as shown in Table 10 (P> 0.05).

Figure 112006062440174-PAT00004
Figure 112006062440174-PAT00004

5. 5. liposomalliposomal GCMGCM 의 제조Manufacture

250mL 둥근 플라스크 용기에 얻어진 GCM 1g과 레시틴(lecithin) 2g을 클로로포름(chloroform):메탄올(methanol)이 2:1(v/v) 용매에 잘 녹인 후 evaporator로 용매를 제거한다. 여기에 물 47mL를 넣은 후 균질기(homogenizer)로 60분간 고속으로 교반하여 균질된 현탁액(homogenized suspension)을 만든다. 다른 250mL 비커에 크산탄 검(xanthane gum 2g을 물 48mL에 완전히 녹여 겔상으로 만든다. 위의 두 물질을 교반하면서 섞어 1%의 겔형 GCM을 완성한다.1 g of GCM and 2 g of lecithin were dissolved in a 250 mL round flask, and chloroform: methanol was dissolved in a 2: 1 (v / v) solvent, and then the solvent was removed by an evaporator. 47 mL of water was added thereto, followed by stirring at high speed for 60 minutes with a homogenizer to make a homogenized suspension. In another 250 mL beaker, 2 g of xanthane gum is completely dissolved in 48 mL of water to make a gel. The above materials are mixed with stirring to complete the 1% gel GCM.

이와 같이 생성된 겔형 GCM은 기능성화장품, 골다공증 치료제 등에 다양하게 사용가능하다.Gel GCM thus produced can be used in a variety of functional cosmetics, osteoporosis therapeutics and the like.

또한, 배양된 홍국균과 배지는 오븐에서 110℃로 수분함량 10% 이하가 되도록 건조하여 분말로 제조하여 사용할 수도 있다. In addition, the cultured red yeast bacteria and the medium may be dried to 110% or less moisture content in the oven to prepare a powder.

그리고, 상기한 바와 같이 제조된 GCM을 갖는 홍국균과 배양액을 이용하여 쌀을 가공하는데, 그 과정을 살펴보면, 백미를 물에 충분히 잠기도록 수침시켜 8-12시간 경과시켜 수분함량 45% 이상이 되도록 한 후, 100-140℃에서 10-20분 증자한 후, 여기에 GCM을 갖는 홍국균과 배양액을 증자한 쌀중량에 대하여 5-10% 첨가하여 20-40℃ 인큐베이터에서 10-14일간 배양하여 쌀에 GCM성분이 함유되도록 한 것이다.In addition, the rice is processed using the hongguk bacteria and culture medium having the GCM prepared as described above, look at the process, soaking the white rice soaked in water enough to immerse 8-12 hours to be more than 45% moisture content Then, after 10-20 minutes increase at 100-140 ℃, 5-10% by weight of the rice and the culture medium with GCM and GCM added thereto, incubated for 10-14 days in a 20-40 ℃ incubator to rice It is to contain the GCM component.

상기한 바와 같이 구성된 본 발명에 의하면 분리 및 용해도에 의한 저비용의 배당체 제니스테인의 분리기술 확립으로 경제적인 이익의 극대화가 가능하고, 홍국균을 이용한 비배당체 이소플라본과 모나콜린 케이(Monacolin K)를 동시에 가지는 GCM의 획득을 통하여 보다 효율적인 고지혈증 건강기능식품의 생산기술을 확보할 수 있게 된다.According to the present invention configured as described above, it is possible to maximize the economic benefits by establishing a separation technology of low-cost glycoside genistein by separation and solubility, and simultaneously having a non-glycoside isoflavone and monacoline K using Monukolin K. Acquisition of GCM will ensure the production of more efficient hyperlipidemic functional food production technology.

그리고 대두와 더불어 두부생산 공정에서 발생하는 부산물인 비지에서 콩의 주요 기능성 성분인 이소플라본을 분리할 수 있어서 원자재의 원가절감효과와 더불어 폐자원의 활용이라는 점에서 중요한 가치를 가진다.In addition to soybeans, it is possible to separate isoflavones, which are the main functional components of soybeans, from bean curd, which is a by-product of the tofu production process, which is important in terms of cost savings of raw materials and utilization of waste resources.

또한, 생성된 GCM은 콜레스테롤 억제를 통한 고지혈증 및 심장질환 개선제로 이용이 가능하며, 모나콜린 케이의 골세포 촉진작용과 제니스테인의 파골세포 억제 등을 통한 골다공증 치료에 효과가 있다.In addition, the generated GCM can be used as an agent for improving hyperlipidemia and heart disease through cholesterol inhibition, and is effective in treating osteoporosis through osteoclast promotion of monacoline K and osteoclast inhibition of genistein.

또한, 본 발명의 제니스틴 추출 과정은 종래의 콩과 식물에서 이소플라본을 분리하는 방법으로 주로 사용되는 칼럼 크로마토그래피(column chromatography)를 이용하여 글리코사이드 이소플라본(glycoside isoflavone)을 분리한 다음, 산이나 효소를 이용하여 아글루콘 이소플라본(aglucone isoflavone)을 얻는 방법에 비하여, 고농도의 글리코사이드 이소플라본인 제니스틴을 에탄올 수용액의 용해도 차이를 이용하여 보다 효과적으로 분리할 수 있다.In addition, the genistin extraction process of the present invention is to separate the glycoside isoflavones by column chromatography, which is mainly used as a method for separating isoflavones from conventional legumes, and then Compared to the method of obtaining an aglucone isoflavone using an enzyme, a high concentration of glycoside isoflavone, zenistine, can be separated more effectively by using a difference in solubility of ethanol aqueous solution.

Claims (8)

콩 분말 1kg에 대하여 1-3L의 핵산을 2-4회 반복해서 가하여 10시간 교반한 후, 필터링하여 탈지된 콩 분말을 제조하는 탈지과정과,Degreasing process of adding 1-3L nucleic acid 2-4 times with respect to 1kg of soybean powder and stirring for 10 hours, and then filtered to produce skim soybean powder, 탈지된 콩 분말 700g에 대하여 상온에서 0.5-2L의 80% 에탄올 수용액을 2-5회 반복하여 가하여 4-6시간 교반하여 10% 내외의 이소플라본을 얻는 10% 이소플라본 추출 과정과,10% isoflavone extraction process of adding 0.5-2L of 80% ethanol aqueous solution 2-5 times at room temperature and stirring for 4-6 hours to obtain 10% isoflavones at about 700g of soybean powder, 상기한 10% 내외의 이소플라본 10g에 95% 에탄올 수용액(aq. ethanol) 100-150mL를 첨가한 후 70-90℃에서 30분에서 1-3시간 교반한 후 여과한 다음 용매를 감압여과하여 제거함으로써 50% 이상의 이소플라본을 얻는 과정인 것을 특징으로 하는 이소플라본 제조 방법.100-150 mL of an aqueous 95% ethanol solution (aq. Ethanol) was added to 10 g of the above-mentioned 10% isoflavones, stirred at 70-90 ° C. for 30 minutes at 1-3 minutes, filtered, and then the solvent was filtered off under reduced pressure. Isoflavone production method, characterized in that the process to obtain 50% or more isoflavones. 비지를 건조 오븐에서 100-150℃에서 수분함량 10%이하가 되도록 완전히 건조하는 건조과정과,A drying process of drying the paper completely in a drying oven so that the moisture content is 10% or less at 100-150 ° C; 건조된 콩비지분말 700g에 대하여 상온에서 0.5-2L의 80% 에탄올 수용액을 2-5회 반복하여 가하여 4-6시간 교반하여 10% 내외의 이소플라본을 얻는 10% 이소플라본 추출 과정과,10% isoflavone extraction process of adding 0.5-2L of 80% ethanol aqueous solution 2-5 times at room temperature to the dried bean bean powder 700g and stirring for 4-6 hours to obtain isoflavones of about 10%; 상기한 10% 내외의 이소플라본 10g에 95% 에탄올 수용액(aq. ethanol) 100-150mL를 첨가한 후 70-90℃에서 30분에서 1-3시간 교반한 후 여과한 다음 용매를 감압여과하여 제거함으로써 50% 이상의 이소플라본을 얻는 과정인 것을 특징으로 하는 이소플라본 제조 방법.100-150 mL of an aqueous 95% ethanol solution (aq. Ethanol) was added to 10 g of the above-mentioned 10% isoflavones, stirred at 70-90 ° C. for 30 minutes at 1-3 minutes, filtered, and then the solvent was filtered off under reduced pressure. Isoflavone production method, characterized in that the process to obtain 50% or more isoflavones. 콩 혹은 콩비지로부터 추출된 이소플라본 1g에 대하여 60-90% 에탄올 수용액 80-120mL를 추가하여 70-90℃에서 10-30분간 환류 추출한 다음 필터링하고 5-15℃로 급속냉각한 후 12-36시간 경과시켜 제니스틴을 얻는 것을 특징으로 하는 제니스틴 제조 방법.Add 80-120 mL of 60-90% ethanol aqueous solution to 1 g of isoflavones extracted from soybean or soybeans, reflux for 10-30 minutes at 70-90 ° C, filter, rapidly cool to 5-15 ° C, and then 12-36 hours. Genistin production method characterized by passing over. 제니스틴을 50-85% 에탄올에 0.1 내지 1중량% 용해하여 pH는 5-7로 조정된 배지에 0.01-0.2중량% 첨가하여 홍국균을 배양하여 홍국균이 모나콜린 케이를 함유하는 제니스테인을 갖도록 하는 것을 특징으로 하는 모나콜린 케이를 함유하는 제니스테인을 갖는 홍국균 배양 방법.Dissolve 0.1-1% by weight of Genistin in 50-85% ethanol and add 0.01-0.2% by weight to the medium adjusted to pH 5-7 to cultivate the red mussel bacterium so that the red mucus has genistein containing Monacholine K. A method for culturing red yeast bacteria having Genistein containing Monacholine K. 제 4항에 있어서, 상기한 제니스틴은 액상으로 첨가되는 것을 특징으로 하는 모나콜린 케이를 함유하는 제니스테인을 갖는 홍국균 배양 방법.The method according to claim 4, wherein the genistin is added in a liquid phase. 모나콜린 케이를 함유하는 제니스테인을 갖는 홍국균과 배지를 오븐에서 110℃로 수분함량 10% 이하가 되도록 건조하는 것을 특징으로 하는 모나콜린 케이를 함유하는 제니스테인을 갖는 분말 제조 방법.A method for producing a powder having genistein containing monacholine k, characterized in that the honggyun bacteria having genistein containing monacoline k and the medium are dried in an oven at 110 ° C. to have a water content of 10% or less. 청구항 6에서 얻어진 모나콜린 케이를 함유하는 제니스테인을 갖는 홍국분말 1g에 대하여 레시틴 1.5-3g을 클로로포름:메탄올이 2:1의 부피비로 혼합된 용매에 녹인 후 용매를 이베퍼레이터를 사용하여 제거하고, 1.5 g of lecithin was dissolved in a solvent in which chloroform: methanol was mixed in a volume ratio of 2: 1 with respect to 1 g of red yeast powder having Genistein containing Monacholine K, and the solvent was removed using an evaporator. 생성된 물질의 중량에 대하여 물 50-60mL를 넣은 후 50-70분간 고속 교반하여 균질화된 현탁액을 제조하며,50-60 mL of water is added to the weight of the resulting material, and then stirred at high speed for 50-70 minutes to prepare a homogenized suspension. 크산탄 검 1-5g을 물 40-60mL에 완전히 녹여 겔상으로 만든 후, After dissolving 1-5 g of xanthan gum in 40-60 mL of water to make a gel, 상기 균질화된 현탁액과 겔상의 크산탄 검을 교반하면서 섞어서 겔형으로 제조하는 것을 특징으로 하는 모나콜린 케이를 함유하는 제니스테인을 갖는 겔 제조 방법. A method for producing a gel having genistein containing Monacholine K, characterized in that the homogenized suspension and gelled xanthan gum are mixed with stirring to prepare a gel. 백미를 물에 충분히 잠기도록 수침시켜 8-12시간 경과시켜 수분함량 45% 이상이 되도록 한 후, 100-140℃에서 10-20분 증자하고, 여기에 모나콜린 케이를 함유하는 제니스테인을 갖는 홍국균과 배지를 증자한 쌀중량에 대하여 5-10% 첨가하여 20-40℃ 인큐베이터에서 10-14일간 배양한 것을 특징으로 하는 모나콜린 케이를 함유하는 제니스테인을 갖는 쌀 제조 방법.After immersing the white rice in water to immerse it in water for 8-12 hours to make the water content 45% or more, increase the temperature at 100-140 ° C for 10-20 minutes, and the red yeast bacterium with Genistein containing Monacholine K. A method for producing rice having zenithine containing Monacholine K, wherein the medium is added 5-10% with respect to the weight of cooked rice and incubated in a 20-40 ° C. incubator for 10-14 days.
KR1020060082415A 2006-08-29 2006-08-29 Manufacturing method of Monascus sp., powder, gel, rice with Genistein Combined Monacolin K KR100858280B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060082415A KR100858280B1 (en) 2006-08-29 2006-08-29 Manufacturing method of Monascus sp., powder, gel, rice with Genistein Combined Monacolin K

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060082415A KR100858280B1 (en) 2006-08-29 2006-08-29 Manufacturing method of Monascus sp., powder, gel, rice with Genistein Combined Monacolin K

Publications (2)

Publication Number Publication Date
KR20080019902A true KR20080019902A (en) 2008-03-05
KR100858280B1 KR100858280B1 (en) 2008-09-11

Family

ID=39395006

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060082415A KR100858280B1 (en) 2006-08-29 2006-08-29 Manufacturing method of Monascus sp., powder, gel, rice with Genistein Combined Monacolin K

Country Status (1)

Country Link
KR (1) KR100858280B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102349637A (en) * 2011-10-15 2012-02-15 广东美味鲜调味食品有限公司 Preserved bean curd sauce and preparation method thereof
CN102491965A (en) * 2011-11-17 2012-06-13 四川省中医药科学院 Method for preparing genistein

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554519A (en) 1995-08-07 1996-09-10 Fermalogic, Inc. Process of preparing genistein
US5702752A (en) 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
KR20010007901A (en) * 1999-10-20 2001-02-05 서주원 β-Glucosidase obtained from oats and process for preparation of genistein or daidzein using it
KR20010047621A (en) * 1999-11-22 2001-06-15 오인갑 Extracts of soybean and process for preparation thereof
KR100400631B1 (en) * 2001-05-08 2003-10-04 주식회사 이지바이오시스템 Process for the preparation of barley containing calcium
KR20030095669A (en) * 2002-06-14 2003-12-24 주식회사 렉스진바이오텍 Isoflavon obtained from natural material, process for preparing the same, and use thereof
KR20040048225A (en) * 2002-12-02 2004-06-07 주식회사 렉스진바이오텍 A method for preparing isoflabone-containing extract from by-product of the pulse, and pharmaceutical preparation and health aid food containing the extract produced by said method
KR20050082694A (en) * 2004-02-20 2005-08-24 (주) 바이오팜 Red yeast rice with high-content of activated monacolin-k and process for preparing the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102349637A (en) * 2011-10-15 2012-02-15 广东美味鲜调味食品有限公司 Preserved bean curd sauce and preparation method thereof
CN102491965A (en) * 2011-11-17 2012-06-13 四川省中医药科学院 Method for preparing genistein
CN102491965B (en) * 2011-11-17 2013-09-25 四川省中医药科学院 Method for preparing genistein

Also Published As

Publication number Publication date
KR100858280B1 (en) 2008-09-11

Similar Documents

Publication Publication Date Title
US8940789B2 (en) Neurite elongation agent, memory-improving agent and anti-Alzheimer agent comprising 4′-demethylnobiletin or 4′-demethyltangeretin as active ingredient, and process for production of the compound
EP2474237B1 (en) Equol-containing fermentation product of soybean embryonic axis, and method for production thereof
US7033621B1 (en) Isoflavone compositions produced from legumes
FI120648B (en) Process for the preparation of arachidonic acid
KR102137252B1 (en) fermented extract for preventing stress alopecia using Lactobacillus plantarum J2K-27, and manufacturing method of it, and cosmetic composition containing fermented extract
CN109517740B (en) Monascus purpureus mutant strain, water-soluble functional red yeast and preparation method and application thereof
CA2288321C (en) Preparation of isoflavones from legumes
CN102362627A (en) Healthcare coffee containing cordyceps
JP4587442B2 (en) Novel antihyperlipidemic agent and food
JP6970992B2 (en) Eel femaleization induction method, eel breeding method, eel femaleizing agent, and eel feed
KR101326271B1 (en) The manufacturing method of fermented citrus peel extract with anti-obesity nature and the product
TWI820342B (en) Uses of chenopodium formosanum extract in preparing composition for resisting natural aging and promoting lipolysis and reducing fat accumulation and a fat reducing composition
EP2963049B1 (en) Method for preparing coumestrol
KR100858280B1 (en) Manufacturing method of Monascus sp., powder, gel, rice with Genistein Combined Monacolin K
KR20090041083A (en) A manufacturing method of green tea vinegar
KR101804727B1 (en) Method for manufacturing fermented safflower pill
CN105535035A (en) Inonotus obliquus fermentation culture composition and preparation method thereof
JP2022022349A (en) Methods for producing equol-containing compositions
CN1536069B (en) Method for large-scale production of catepillar fungus and lucid ganoderma
KR100403565B1 (en) a manufacturing process feeds which be made from a Tofuwast redkoji containing monacolin
CN108771070B (en) Compound functional beverage prepared by fermenting celery juice with eurotium cristatum, preparation method and application
EP1637609A1 (en) Equol-enriched plant extract obtainable by fermentation
WO2003077904A1 (en) Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon
KR20140054953A (en) Antioxidant cosmetic composition containing mixture of fermented herbal extracts
KR102289630B1 (en) Composition for hangover annul food based on germination plants and oriental medicine materials, manufacturing method thereof and hangover annul food manufactured by the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120305

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee